Detection and Clinical Implications of Circulating Tumor Cells in Cancer PatientsProfessor Klaus Pantel, University Medical Center Hamburg-Eppendorf, speaking at Molecular Medicine Congress 2013.
Proteomics of Triple-negative Breast CancerMetodi Metodiev, University of Essex, speaking at Systems Biology Europe 2012
Circulating Tumor Antigens and their Autoantibody Reactivity as Cancer MarkersSamir Hanash, Program Head, Fred Hutchinson Cancer Research Center, speaking at CellTech 2013.
Harmonization and Standardization of CNS BiomarkersRivka Ravid, Royal Dutch Academy of Sciences, speaking at European Lab Automation 2013.
The Development of Stapled Peptides that Modulate the BRCA2-RAD51 InteractionChiara Valenzano, University of Cambridge, speaking at Discovery Chemistry Congress 2013.
Inhibition of Protein-protein Interactions Using Designed MoleculesAndrew Wilson, University of Leeds, speaking at Discovery Chemistry Congress 2013.
Druggability of Dynamic Protein-Protein Interfaces Volkhard Helms, Universitat des Saarlandes, speaking at Discovery Chemistry Congress 2013.
Library Design for Tackling Protein-protein Interactions: The 2P2I ApproachDr Philippe Roche, CNRS, speaking at Discovery Chemistry Congress 2013.
PASylation: the Biological Alternative to PEGylationUli Binder, XL Protein GmbH, speaking at Discovery Chemistry Congress 2013.
About Us | Advertise On This Site | Cookies | Contact Us | Home | Support | Terms & Conditions